Gemelli Biotech: Funding, Investors & Team (Oct 2026)
Gemelli is a biotechnology organization that has practical experience in the microbiome, and IBS diagnostics. It endeavors to accomplish a flourishing worldwide group of solid people by opening the capability of the microbiome. The organization is driven by its central goal is to help the disclosure of novel diagnostics and therapeutics for the human microbiome by putting up biotechnology developments for sale to the public in a monetarily dependable and socially cognizant way. The organization was established in 2018 and settled in North Carolina, United States.
Gemelli Biotech has raised $19.0M across 1 funding round on record, the most recent a Series A of $19.0M announced in Jun 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gemelli Biotech Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Gemelli Biotech Funding Rounds
Gemelli Biotech Founders and Leadership Team
Contact details for the Gemelli Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Gemelli Biotech Funding Compared to Other Biotechnology Startups
Gemelli Biotech's latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gemelli Biotech in Biotechnology and Raleigh
Companies Similar to Gemelli Biotech
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Gemelli Biotech Funding FAQs
What does Gemelli Biotech do?
Gemelli is a biotechnology organization that has practical experience in the microbiome, and IBS diagnostics. It endeavors to accomplish a flourishing worldwide group of solid people by opening the capability of the microbiome. The organization is driven by its central goal is to help the disclosure of novel diagnostics and therapeutics for the human microbiome by putting up biotechnology developments for sale to the public in a monetarily dependable and socially cognizant way. The organization was established in 2018 and settled in North Carolina, United States.
How much funding has Gemelli Biotech raised?
Gemelli Biotech has raised $19.0M across 1 round on record. The most recent is a Series A of $19.0M announced in Jun 2022.
When did Gemelli Biotech last raise funding?
Gemelli Biotech's most recent funding round on record is a Series A of $19.0M, announced in Jun 2022.
Who founded Gemelli Biotech?
FundedIQ lists Mark Pimentel (Founder) at Gemelli Biotech.
Where is Gemelli Biotech headquartered?
Gemelli Biotech is based in Raleigh, North Carolina, United States.
How many employees does Gemelli Biotech have?
Gemelli Biotech is in the 11-50 employee band.
How does Gemelli Biotech's funding compare to other Biotechnology startups?
Gemelli Biotech's latest round of $19.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gemelli Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gemelli Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.